Jeske W - Search Results

1

Andexanet Alfa Neutralizes the Anticoagulant Effects of Unfractionated Heparin of Bovine, Ovine and Porcine Origin Almost as Protamine Sulfate.

Siddiqui F, Hoppensteadt D, Jeske W, Ramacciotti E, Tafur A, Fareed J. Siddiqui F, et al. Among authors: jeske w. Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241247558. doi: 10.1177/10760296241247558. Clin Appl Thromb Hemost. 2024. PMID: 38656136 Free PMC article.

2

Fondaparinux: a synthetic heparin pentasaccharide as a new antithrombotic agent.

Walenga JM, Jeske WP, Samama MM, Frapaise FX, Bick RL, Fareed J. Walenga JM, et al. Expert Opin Investig Drugs. 2002 Mar;11(3):397-407. doi: 10.1517/13543784.11.3.397. Expert Opin Investig Drugs. 2002. PMID: 11866668 Review.

3

Prevalence, isotype, and functionality of antiheparin-platelet factor 4 antibodies in patients treated with heparin and clinically suspected for heparin-induced thrombocytopenia. The pathogenic role of IgG.

Untch B, Ahmad S, Jeske WP, Messmore HL, Hoppensteadt DA, Walenga JM, Lietz H, Fareed J. Untch B, et al. Thromb Res. 2002 Jan 15;105(2):117-23. doi: 10.1016/s0049-3848(02)00004-x. Thromb Res. 2002. PMID: 11958801

4

Molecular and biochemical profiling of a heparin-derived oligosaccharide, C3.

Ma Q, Dudas B, Daud A, Iqbal O, Hoppensteadt D, Jeske W, Cornelli U, Lee J, Lorens S, Mervis R, Hanin I, Capila I, Linhardt R, Fareed J. Ma Q, et al. Among authors: jeske w. Thromb Res. 2002 Feb 15;105(4):303-9. doi: 10.1016/s0049-3848(01)00413-3. Thromb Res. 2002. PMID: 12031824

5

Effects of a synthetic factor Xa inhibitor (JTV-803) on various laboratory tests.

Tobu M, Iqbal O, Hoppensteadt DA, Shultz C, Jeske W, Fareed J. Tobu M, et al. Among authors: jeske w. Clin Appl Thromb Hemost. 2002 Oct;8(4):325-36. doi: 10.1177/107602960200800404. Clin Appl Thromb Hemost. 2002. PMID: 12516682 Free article.

6

Differential effects of clivarin and heparin in patients undergoing hip and knee surgery for the generation of anti-heparin-platelet factor 4 antibodies.

Ahmad S, Haas S, Hoppensteadt DA, Lietz H, Reid U, Bender N, Messmore HL, Misselwitz F, Bacher P, Gaikwad BS, Jeske WP, Walenga JM, Fareed J. Ahmad S, et al. Thromb Res. 2002 Oct 1;108(1):49-55. doi: 10.1016/s0049-3848(02)00397-3. Thromb Res. 2002. PMID: 12586132 Clinical Trial.

7

Global anticoagulant effects of a synthetic anti-factor Xa inhibitor (DX-9065a): implications for interventional use.

Tobu M, Iqbal O, Ma Q, Schultz C, Jeske W, Hoppensteadt D, Lewis B, Fareed D, Fareed J. Tobu M, et al. Among authors: jeske w. Clin Appl Thromb Hemost. 2003 Jan;9(1):1-17. doi: 10.1177/107602960300900101. Clin Appl Thromb Hemost. 2003. PMID: 12643318 Free article.

8

Factor Xa inhibitors: today and beyond.

Walenga JM, Jeske WP, Hoppensteadt D, Fareed J. Walenga JM, et al. Curr Opin Investig Drugs. 2003 Mar;4(3):272-81. Curr Opin Investig Drugs. 2003. PMID: 12735228 Review.

9

Pharmacodynamic and pharmacokinetic properties of enoxaparin : implications for clinical practice.

Fareed J, Hoppensteadt D, Walenga J, Iqbal O, Ma Q, Jeske W, Sheikh T. Fareed J, et al. Among authors: jeske w. Clin Pharmacokinet. 2003;42(12):1043-57. doi: 10.2165/00003088-200342120-00003. Clin Pharmacokinet. 2003. PMID: 12959635 Review.

10

Factor Xa inhibitors.

Walenga JM, Jeske WP, Hoppensteadt D, Fareed J. Walenga JM, et al. Methods Mol Med. 2004;93:95-117. doi: 10.1385/1-59259-658-4:95. Methods Mol Med. 2004. PMID: 14733330 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

362 results

Search Page

Filters